We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
26
PepsiCo
PEP
$186B
$160M 0.73%
1,171,110
-4,144
-0.4% -$564K
BIIB icon
27
Biogen
BIIB
$29.9B
$158M 0.72%
533,522
-95,565
-15% -$26.5M
FTNT icon
28
Fortinet
FTNT
$112B
$157M 0.72%
7,358,820
-43,330
-0.6% -$815K
INTC icon
29
Intel
INTC
$466B
$155M 0.7%
2,583,441
+11,345
+0.4% +$635K
PG icon
30
Procter & Gamble
PG
$343B
$146M 0.67%
1,170,805
-31,447
-3% -$3.85M
UNH icon
31
UnitedHealth
UNH
$382B
$144M 0.66%
491,154
-131,201
-21% -$34.3M
VB icon
32
Vanguard Small-Cap ETF
VB
$79.5B
$144M 0.66%
871,629
+23,270
+3% +$3.71M
CVX icon
33
Chevron
CVX
$388B
$138M 0.63%
1,147,791
-15,297
-1% -$1.8M
EA icon
34
Electronic Arts
EA
$52.4B
$138M 0.63%
1,282,715
+16,413
+1% +$1.63M
LRCX icon
35
Lam Research
LRCX
$382B
$134M 0.61%
4,568,770
-103,640
-2% -$2.75M
XOM icon
36
ExxonMobil
XOM
$651B
$134M 0.61%
1,913,198
-184,395
-9% -$12.8M
ROST icon
37
Ross Stores
ROST
$76.6B
$133M 0.61%
1,141,387
-330,670
-22% -$37.2M
PFE icon
38
Pfizer
PFE
$140B
$132M 0.6%
3,554,650
+665,654
+23% +$23.7M
VEA icon
39
Vanguard FTSE Developed Markets ETF
VEA
$226B
$125M 0.57%
2,842,842
+98,502
+4% +$4.2M
AMT icon
40
American Tower
AMT
$77.7B
$121M 0.55%
526,711
-9,120
-2% -$1.99M
APH icon
41
Amphenol
APH
$188B
$119M 0.54%
4,382,332
+2,996,184
+216% +$76.5M
KEYS icon
42
Keysight
KEYS
$54.5B
$118M 0.54%
1,152,634
+840,111
+269% +$86M
CDW icon
43
CDW
CDW
$17.1B
$117M 0.53%
819,316
-130,539
-14% -$17.3M
NKE icon
44
Nike
NKE
$61.9B
$112M 0.51%
1,110,379
+831,052
+298% +$78.3M
ABT icon
45
Abbott
ABT
$180B
$106M 0.48%
1,220,406
+32,253
+3% +$2.7M
CDNS icon
46
Cadence Design Systems
CDNS
$90B
$104M 0.47%
1,495,402
-258,277
-15% -$17.3M
PNC icon
47
PNC Financial Services
PNC
$100B
$103M 0.47%
642,739
+2,781
+0.4% +$417K
TJX icon
48
TJX Companies
TJX
$170B
$100M 0.46%
1,637,442
-20,031
-1% -$1.18M
MCK icon
49
McKesson
MCK
$98.5B
$99.8M 0.46%
721,758
+285,200
+65% +$40.3M
RTX icon
50
RTX Corp
RTX
$287B
$98M 0.45%
1,039,432
+18,190
+2% +$1.65M

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.